首页 > 最新文献

Journal of Neuro-Ophthalmology最新文献

英文 中文
Blurry Vision and Multiple Cranial Neuropathies. 视力模糊和多发性颅神经病。
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2024-05-17 DOI: 10.1097/WNO.0000000000002180
Eliot D Smolyansky, Subahari Raviskanthan, Anthony Fok
{"title":"Blurry Vision and Multiple Cranial Neuropathies.","authors":"Eliot D Smolyansky, Subahari Raviskanthan, Anthony Fok","doi":"10.1097/WNO.0000000000002180","DOIUrl":"10.1097/WNO.0000000000002180","url":null,"abstract":"","PeriodicalId":16485,"journal":{"name":"Journal of Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140957889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clues From Parinaud: Diagnostic Approaches in Neuro-Ophthalmology. 帕里诺德的线索:神经眼科的诊断方法。
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2023-08-04 DOI: 10.1097/WNO.0000000000001966
Daniel N de Souza, Carter A Bell, Zachary P Elkin, Scott N Grossman
{"title":"Clues From Parinaud: Diagnostic Approaches in Neuro-Ophthalmology.","authors":"Daniel N de Souza, Carter A Bell, Zachary P Elkin, Scott N Grossman","doi":"10.1097/WNO.0000000000001966","DOIUrl":"10.1097/WNO.0000000000001966","url":null,"abstract":"","PeriodicalId":16485,"journal":{"name":"Journal of Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9948613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dynamic Changes in Metabolic Status Are Associated With Risk of Ocular Motor Cranial Nerve Palsies. 代谢状态的动态变化与眼球运动性颅神经麻痹的风险有关。
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2023-08-31 DOI: 10.1097/WNO.0000000000001978
Daye Diana Choi, Kyung-Ah Park, Kyungdo Han, Sei Yeul Oh

Background: To investigate whether recovery from or development of metabolic syndrome (MetS) in a population is associated with an altered risk for ocular motor cranial nerve palsy (CNP).

Methods: This cohort study included 4,233,273 adults without a history of ocular motor cranial nerve palsy (ocular motor CNP) who underwent 2 consecutive biennial health screenings provided by the Korean National Health Insurance System between 2009 and 2011. They were followed up until December 31, 2018. Participants were categorized into a MetS-free, MetS-developed, MetS-recovered, or MetS-chronic group. A multivariable Cox proportional hazard regression model was used. Model 3 was adjusted for age, sex, smoking status, alcohol consumption, and physical activity.

Results: Compared with the MetS-free group, the MetS-chronic group had the highest risk of ocular motor CNP (hazard ratio [HR]: 1.424; 95% confidential interval [CI]: 1.294-1.567, Model 3), followed by the MetS-developed group (HR: 1.198, 95% CI: 1.069-1.343), and the MetS-recovered group (HR: 1.168, 95% CI: 1.026-1.311) after adjusting for potential confounders. The hazard ratio of ocular motor CNP in men with chronic MetS was 1.566 (95% CI, 1.394-1.761) while that of women with chronic MetS was 1.191 (95% CI, 1.005-1.411). Among age groups, those in their 30s and 40s showed the highest association between dynamic MetS status and ocular motor CNP.

Conclusions: In our study, recovering from MetS was associated with a reduced risk of ocular motor CNP compared with chronic MetS, suggesting that ocular motor CNP risk could be managed by changing MetS status.

背景:研究人群中代谢综合征(MetS)的恢复或发展是否与眼部运动性颅神经麻痹(CNP)风险的改变有关:研究人群中代谢综合征(MetS)的恢复或发展是否与眼球运动性颅神经麻痹(CNP)风险的改变有关:这项队列研究纳入了 4233273 名无眼球运动性颅神经麻痹(眼球运动性颅神经麻痹)病史的成年人,他们在 2009 年至 2011 年间连续两次接受了韩国国民健康保险系统提供的两年一次的健康检查。对他们进行了随访,直至 2018 年 12 月 31 日。参与者被分为无 MetS 组、MetS 发展组、MetS 恢复组和 MetS 慢性组。采用多变量考克斯比例危险回归模型。模型3对年龄、性别、吸烟状况、饮酒量和运动量进行了调整:结果:与无 MetS 组相比,MetS 慢性组患眼球运动性 CNP 的风险最高(危险比 [HR]:1.424;95% 置信度 [HR]:1.424;95% 置信度 [HR] :1.424):1.424;95% 置信区间 [CI]:模型 3),其次是 MetS 发展组(HR:1.198,95% 置信区间 [CI]:1.069-1.343)和 MetS 恢复组(HR:1.168,95% 置信区间 [CI]:1.026-1.311)。慢性 MetS 男性患者的眼部运动神经元高压危险比为 1.566(95% CI,1.394-1.761),而慢性 MetS 女性患者的危险比为 1.191(95% CI,1.005-1.411)。在各年龄组中,30 多岁和 40 多岁人群的动态 MetS 状态与眼球运动性 CNP 的关联度最高:在我们的研究中,与慢性 MetS 相比,恢复期 MetS 与眼球运动性 CNP 风险降低相关,这表明眼球运动性 CNP 风险可通过改变 MetS 状态来控制。
{"title":"Dynamic Changes in Metabolic Status Are Associated With Risk of Ocular Motor Cranial Nerve Palsies.","authors":"Daye Diana Choi, Kyung-Ah Park, Kyungdo Han, Sei Yeul Oh","doi":"10.1097/WNO.0000000000001978","DOIUrl":"10.1097/WNO.0000000000001978","url":null,"abstract":"<p><strong>Background: </strong>To investigate whether recovery from or development of metabolic syndrome (MetS) in a population is associated with an altered risk for ocular motor cranial nerve palsy (CNP).</p><p><strong>Methods: </strong>This cohort study included 4,233,273 adults without a history of ocular motor cranial nerve palsy (ocular motor CNP) who underwent 2 consecutive biennial health screenings provided by the Korean National Health Insurance System between 2009 and 2011. They were followed up until December 31, 2018. Participants were categorized into a MetS-free, MetS-developed, MetS-recovered, or MetS-chronic group. A multivariable Cox proportional hazard regression model was used. Model 3 was adjusted for age, sex, smoking status, alcohol consumption, and physical activity.</p><p><strong>Results: </strong>Compared with the MetS-free group, the MetS-chronic group had the highest risk of ocular motor CNP (hazard ratio [HR]: 1.424; 95% confidential interval [CI]: 1.294-1.567, Model 3), followed by the MetS-developed group (HR: 1.198, 95% CI: 1.069-1.343), and the MetS-recovered group (HR: 1.168, 95% CI: 1.026-1.311) after adjusting for potential confounders. The hazard ratio of ocular motor CNP in men with chronic MetS was 1.566 (95% CI, 1.394-1.761) while that of women with chronic MetS was 1.191 (95% CI, 1.005-1.411). Among age groups, those in their 30s and 40s showed the highest association between dynamic MetS status and ocular motor CNP.</p><p><strong>Conclusions: </strong>In our study, recovering from MetS was associated with a reduced risk of ocular motor CNP compared with chronic MetS, suggesting that ocular motor CNP risk could be managed by changing MetS status.</p>","PeriodicalId":16485,"journal":{"name":"Journal of Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10128022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recovery of Third, Fourth, and Sixth Cranial Nerve Palsies in Pituitary Adenoma and Meningioma Patients. 垂体腺瘤和脑膜瘤患者第三、第四和第六颅神经麻痹的恢复情况。
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2023-09-04 DOI: 10.1097/WNO.0000000000001990
Li-Pei J Lu, Iris C M Pelsma, Friso de Vries, Saskia P A van Hulst-Ginjaar, Wouter R van Furth, Marco J T Verstegen, Fleur L Fisher, Amir H Zamanipoor Najafadabadi, Nienke R Biermasz, Stijn W van der Meeren, Irene C Notting

Background: This retrospective, observational cohort study aimed to determine recovery rate and recovery time of ocular motor nerve palsies (OMP) of third (CN III), fourth (CN IV), or sixth cranial nerves (CN VI)-and associated prognostic factors-in meningioma and pituitary adenoma (PA) patients.

Methods: A total of 25 meningioma (28 eyes) and 33 PA patients (36 eyes), treated at the Leiden University Medical Center in the Netherlands from January 1, 1978 to January 31, 2021, were included. OMPs were evaluated according to a newly created recovery scale using on-clinical and orthoptic examinations, which were performed every 3-4 months until palsy recovery, or at 18 months follow-up.

Results: Recovery rates of CN III (meningioma 23.5% vs PA 92.3%), CN IV (meningioma 20% vs PA 100%), and CN VI (meningioma 60% vs PA 100%) palsies were observed at 18 months follow-up, with differences between the 2 tumor types being observed in the treated patients only. Median recovery time of all OMPs combined was significantly longer in meningioma patients (37.9 ± 14.3 months vs 3.3 ± 0.1 months; P < 0.001). No significant protective or risk factors for recovery rate or time were identified.

Conclusions: OMP recovery rates in treated patients were more favorable in patients with PA compared with patients with meningiomas, independent of OMP cause. With these new insights in OMP recovery, more accurate prognoses and appropriate follow-up strategies can be determined for meningioma and PA patients with OMPs.

背景:这项回顾性、观察性队列研究旨在确定脑膜瘤和垂体腺瘤(PA)患者第三颅神经(CN III)、第四颅神经(CN IV)或第六颅神经(CN VI)眼运动神经麻痹(OMP)的恢复率和恢复时间,以及相关的预后因素:方法:共纳入了 25 名脑膜瘤患者(28 只眼)和 33 名垂体腺瘤患者(36 只眼),这些患者于 1978 年 1 月 1 日至 2021 年 1 月 31 日在荷兰莱顿大学医学中心接受了治疗。每3-4个月进行一次临床和正视检查,直到麻痹恢复或随访18个月,根据新创建的恢复量表对OMP进行评估:结果:在18个月的随访中观察到CN III(脑膜瘤23.5% vs PA 92.3%)、CN IV(脑膜瘤20% vs PA 100%)和CN VI(脑膜瘤60% vs PA 100%)麻痹的恢复率,仅在接受治疗的患者中观察到两种肿瘤类型之间的差异。脑膜瘤患者所有 OMPs 的中位恢复时间明显更长(37.9 ± 14.3 个月 vs 3.3 ± 0.1 个月;P < 0.001)。没有发现对恢复率或时间有明显影响的保护因素或风险因素:结论:与脑膜瘤患者相比,接受治疗的 PA 患者的 OMP 恢复率更高,这与 OMP 的病因无关。有了这些关于 OMP 恢复的新认识,就能为脑膜瘤和 PA 患者的 OMP 确定更准确的预后和更适当的随访策略。
{"title":"Recovery of Third, Fourth, and Sixth Cranial Nerve Palsies in Pituitary Adenoma and Meningioma Patients.","authors":"Li-Pei J Lu, Iris C M Pelsma, Friso de Vries, Saskia P A van Hulst-Ginjaar, Wouter R van Furth, Marco J T Verstegen, Fleur L Fisher, Amir H Zamanipoor Najafadabadi, Nienke R Biermasz, Stijn W van der Meeren, Irene C Notting","doi":"10.1097/WNO.0000000000001990","DOIUrl":"10.1097/WNO.0000000000001990","url":null,"abstract":"<p><strong>Background: </strong>This retrospective, observational cohort study aimed to determine recovery rate and recovery time of ocular motor nerve palsies (OMP) of third (CN III), fourth (CN IV), or sixth cranial nerves (CN VI)-and associated prognostic factors-in meningioma and pituitary adenoma (PA) patients.</p><p><strong>Methods: </strong>A total of 25 meningioma (28 eyes) and 33 PA patients (36 eyes), treated at the Leiden University Medical Center in the Netherlands from January 1, 1978 to January 31, 2021, were included. OMPs were evaluated according to a newly created recovery scale using on-clinical and orthoptic examinations, which were performed every 3-4 months until palsy recovery, or at 18 months follow-up.</p><p><strong>Results: </strong>Recovery rates of CN III (meningioma 23.5% vs PA 92.3%), CN IV (meningioma 20% vs PA 100%), and CN VI (meningioma 60% vs PA 100%) palsies were observed at 18 months follow-up, with differences between the 2 tumor types being observed in the treated patients only. Median recovery time of all OMPs combined was significantly longer in meningioma patients (37.9 ± 14.3 months vs 3.3 ± 0.1 months; P < 0.001). No significant protective or risk factors for recovery rate or time were identified.</p><p><strong>Conclusions: </strong>OMP recovery rates in treated patients were more favorable in patients with PA compared with patients with meningiomas, independent of OMP cause. With these new insights in OMP recovery, more accurate prognoses and appropriate follow-up strategies can be determined for meningioma and PA patients with OMPs.</p>","PeriodicalId":16485,"journal":{"name":"Journal of Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11319080/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10533810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Central Nervous System Lymphoma Presenting With Cauda Equina Syndrome and Bilateral Third Nerve Palsies. 原发性中枢神经系统淋巴瘤表现为马尾综合征和双侧第三神经麻痹
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2023-04-19 DOI: 10.1097/WNO.0000000000001858
Armin Handzic, Natalie Barbosa-Brossard, Edward Margolin
{"title":"Primary Central Nervous System Lymphoma Presenting With Cauda Equina Syndrome and Bilateral Third Nerve Palsies.","authors":"Armin Handzic, Natalie Barbosa-Brossard, Edward Margolin","doi":"10.1097/WNO.0000000000001858","DOIUrl":"10.1097/WNO.0000000000001858","url":null,"abstract":"","PeriodicalId":16485,"journal":{"name":"Journal of Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44238335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Without a Cause: Bilateral Acquired Progressive Myelinated Retinal Nerve Fiber Layers. 无原因:双侧获得性进行性有髓神经视网膜纤维层。
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2023-12-05 DOI: 10.1097/WNO.0000000000002051
Jonathan A Alexis, Jane H Lock, Timothy Z Cheong, Joshua R Gollschewsky
{"title":"Without a Cause: Bilateral Acquired Progressive Myelinated Retinal Nerve Fiber Layers.","authors":"Jonathan A Alexis, Jane H Lock, Timothy Z Cheong, Joshua R Gollschewsky","doi":"10.1097/WNO.0000000000002051","DOIUrl":"10.1097/WNO.0000000000002051","url":null,"abstract":"","PeriodicalId":16485,"journal":{"name":"Journal of Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138482407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperacute Central Retinal Artery Occlusion With Normal Fundus: A Diagnostic and Therapeutic Challenge. 眼底正常的超急性视网膜中央动脉闭塞:诊断和治疗的挑战。
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2023-06-02 DOI: 10.1097/WNO.0000000000001893
Allison B Hansen, Kamal Kishore, Kelly L Klein
{"title":"Hyperacute Central Retinal Artery Occlusion With Normal Fundus: A Diagnostic and Therapeutic Challenge.","authors":"Allison B Hansen, Kamal Kishore, Kelly L Klein","doi":"10.1097/WNO.0000000000001893","DOIUrl":"10.1097/WNO.0000000000001893","url":null,"abstract":"","PeriodicalId":16485,"journal":{"name":"Journal of Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9564786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oculomotor and Facial Nerve Palsies After Middle Meningeal Artery Embolization. 中脑膜动脉栓塞术后的眼运动神经和面神经麻痹。
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2023-04-19 DOI: 10.1097/WNO.0000000000001845
Nathan A Lambert-Cheatham, Nathaniel R Pasmanter, Lina Nagia
{"title":"Oculomotor and Facial Nerve Palsies After Middle Meningeal Artery Embolization.","authors":"Nathan A Lambert-Cheatham, Nathaniel R Pasmanter, Lina Nagia","doi":"10.1097/WNO.0000000000001845","DOIUrl":"10.1097/WNO.0000000000001845","url":null,"abstract":"","PeriodicalId":16485,"journal":{"name":"Journal of Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9421636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sepsis-Induced Cavernous Sinus Thrombosis and Superior Orbital Vein Thrombosis. 败血症引发的海绵窦血栓和眼眶上静脉血栓。
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2023-05-15 DOI: 10.1097/WNO.0000000000001881
Nikhil Das, Reem Gonnah, Gabriela M Espinoza
{"title":"Sepsis-Induced Cavernous Sinus Thrombosis and Superior Orbital Vein Thrombosis.","authors":"Nikhil Das, Reem Gonnah, Gabriela M Espinoza","doi":"10.1097/WNO.0000000000001881","DOIUrl":"10.1097/WNO.0000000000001881","url":null,"abstract":"","PeriodicalId":16485,"journal":{"name":"Journal of Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9816461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seropositive Neuromyelitis Optica Spectrum Disorder Presenting With Optic Nerve Sheath Enhancement and Optic Disc Edema Resembling Optic Nerve Sheath Meningioma. 血清反应阳性的视神经脊髓炎谱系障碍伴有类似视神经鞘脑膜瘤的视神经鞘强化和视盘水肿。
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2023-05-29 DOI: 10.1097/WNO.0000000000001894
Alejandro I Marin, Anna V Zarubina, Jeffrey L Bennett, Prem S Subramanian
{"title":"Seropositive Neuromyelitis Optica Spectrum Disorder Presenting With Optic Nerve Sheath Enhancement and Optic Disc Edema Resembling Optic Nerve Sheath Meningioma.","authors":"Alejandro I Marin, Anna V Zarubina, Jeffrey L Bennett, Prem S Subramanian","doi":"10.1097/WNO.0000000000001894","DOIUrl":"10.1097/WNO.0000000000001894","url":null,"abstract":"","PeriodicalId":16485,"journal":{"name":"Journal of Neuro-Ophthalmology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9538360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Neuro-Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1